Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yang Feng

Showing results (1151-1160 of 1,161) with videos related to

Pageof 117
Sort By:
Nature Communications|March 23, 2023
Integrated analysis of genomic and transcriptomic data for the discovery of splice-associated variants in cancerKelsy C Cotto, Yang-Yang Feng, Avinash Ramu, et al.
Pacing and Clinical Electrophysiology : PACE|July 10, 2026
Comparison of Ablation Index-Guided Lesion Size in nGEN and SMARTABLATE: An Ex Vivo Porcine Heart StudyXin-Ru Li, Jie-Wen Yin, Xue-Si Wang, et al.
Neuro-Oncology|January 20, 2024
Prognostic value of DNA methylation subclassification, aneuploidy, and CDKN2A/B homozygous deletion in predicting clinical outcome of IDH mutant astrocytomasKristyn Galbraith, Mekka Garcia, Siyu Wei, et al.
The Journal of Biological Chemistry|December 2, 2023
Singlet oxygen induces cell wall thickening and stomatal density reducing by transcriptome reprogrammingZhong-Wei Zhang, Yu-Fan Fu, Xin-Yue Yang, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 30, 2024
Long-Term Efficacy and Safety of Stapokibart in Adults with Moderate-to-Severe Atopic Dermatitis: An Open-Label Extension, Nonrandomized Clinical TrialYan Zhao, Jing-Yi Li, Bin Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2021
DNMT3A Harboring Leukemia-Associated Mutations Directs Sensitivity to DNA Damage at Replication ForksKartika Venugopal, Yang Feng, Pawel Nowialis, et al.
Cancer Cell|September 13, 2017
Identification of GPC2 as an Oncoprotein and Candidate Immunotherapeutic Target in High-Risk NeuroblastomaKristopher R Bosse, Pichai Raman, Zhongyu Zhu, et al.
Cell Reports|November 29, 2023
Engineering CD276/B7-H3-targeted antibody-drug conjugates with enhanced cancer-eradicating capabilityYang Feng, Jaewon Lee, Liping Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 7, 2017
A Phase II Trial of Neoadjuvant MK-2206, an AKT Inhibitor, with Anastrozole in Clinical Stage II or III <i>PIK3CA</i>-Mutant ER-Positive and HER2-Negative Breast CancerCynthia X Ma, Vera Suman, Matthew P Goetz, et al.
The Lancet. Oncology|September 4, 2025
The effect of TERT promoter mutation on predicting meningioma outcomes: a multi-institutional cohort analysisKarenna J Groff, Ruchit V Patel, Yang Feng, et al.
Pageof 117

Showing results (1151-1160 of 1,161) with videos related to

Sort By:
Pageof 117
Nature Communications|March 23, 2023
Integrated analysis of genomic and transcriptomic data for the discovery of splice-associated variants in cancerKelsy C Cotto, Yang-Yang Feng, Avinash Ramu, et al.
Pacing and Clinical Electrophysiology : PACE|July 10, 2026
Comparison of Ablation Index-Guided Lesion Size in nGEN and SMARTABLATE: An Ex Vivo Porcine Heart StudyXin-Ru Li, Jie-Wen Yin, Xue-Si Wang, et al.
Neuro-Oncology|January 20, 2024
Prognostic value of DNA methylation subclassification, aneuploidy, and CDKN2A/B homozygous deletion in predicting clinical outcome of IDH mutant astrocytomasKristyn Galbraith, Mekka Garcia, Siyu Wei, et al.
The Journal of Biological Chemistry|December 2, 2023
Singlet oxygen induces cell wall thickening and stomatal density reducing by transcriptome reprogrammingZhong-Wei Zhang, Yu-Fan Fu, Xin-Yue Yang, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 30, 2024
Long-Term Efficacy and Safety of Stapokibart in Adults with Moderate-to-Severe Atopic Dermatitis: An Open-Label Extension, Nonrandomized Clinical TrialYan Zhao, Jing-Yi Li, Bin Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2021
DNMT3A Harboring Leukemia-Associated Mutations Directs Sensitivity to DNA Damage at Replication ForksKartika Venugopal, Yang Feng, Pawel Nowialis, et al.
Cancer Cell|September 13, 2017
Identification of GPC2 as an Oncoprotein and Candidate Immunotherapeutic Target in High-Risk NeuroblastomaKristopher R Bosse, Pichai Raman, Zhongyu Zhu, et al.
Cell Reports|November 29, 2023
Engineering CD276/B7-H3-targeted antibody-drug conjugates with enhanced cancer-eradicating capabilityYang Feng, Jaewon Lee, Liping Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 7, 2017
A Phase II Trial of Neoadjuvant MK-2206, an AKT Inhibitor, with Anastrozole in Clinical Stage II or III <i>PIK3CA</i>-Mutant ER-Positive and HER2-Negative Breast CancerCynthia X Ma, Vera Suman, Matthew P Goetz, et al.
The Lancet. Oncology|September 4, 2025
The effect of TERT promoter mutation on predicting meningioma outcomes: a multi-institutional cohort analysisKarenna J Groff, Ruchit V Patel, Yang Feng, et al.
Pageof 117